Scoop has an Ethical Paywall
Cancer detection commercialisation can't be 'overnight'
Cancer detection commercialisation could never be an 'overnight' happening
By Peter Kerr for sticK
(sticK - 30 Nov. 2010 ) Pacific Edge Ltd., is inching its way to commercialisation of its bladder cancer detection tests - showing that it can be done, but never 'overnight'.
Above all it also demonstrates just how much effort it takes to turn an idea, detecting the presence of cancer cells in urine, and turning that into a sellable product - an assay test that is easily and accurately able to be used by urologists and physicians as a diagnostic and prognosis tool.
Along the way the Dunedin-based company has had to prove its methodology in different locations; so far in Australasia, America and Europe, and is now working on the best way to commercially roll out the tests.
For sticK – science, technology, innovation &
commercialisation KNOWLEDGE - is a new Wellington based
news service concentrating on following the money from ideas
to income. Contact editor Peter Kerr at peter.kerr055 @
gmail.com
Peter Kerr
Message maker
Writer, communicator, simplifier, storyteller.
Versed in the art and science of translating something complicated into an understandable message.
Google Threat Intelligence Group - GTIG: Google Threat Report Warns AI-Driven Cyber Operations Are Scaling Across Global Threat Landscape
Commerce Commission: Baseline Research Report On The State Of Competition In New Zealand
University of Auckland: Junk Food Designed To Make Us Eat More, Study Finds
Spark: New Report Sets Out Outcomes-Led Approach To Lift Rural Connectivity Using The Right Mix Of Technologies
Bill Bennett: Fixed Voice Rules Head For Deregulation
UN Department of Global Communications: United Nations Proposes New Global Dashboard To Measure Progress Beyond GDP
